JGP Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-2,690
Closed -$205K 144
2022
Q2
$205K Buy
2,690
+21
+0.8% +$1.6K 0.04% 142
2022
Q1
$208K Buy
+2,669
New +$179K 0.04% 155

Other funds holding BMY

JGP Wealth Management's BMY Position: Q3 2022 in Review

JGP Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q3 2022, closing a stake of 2,690 shares — an estimated $205K sold.

JGP Wealth Management first reported a position in BMY in Q1 2022 and held it in 2 quarters. The position peaked at $208K in Q1 2022. 2,470 funds tracked by Wall St. Rank hold BMY as of Q3 2022.

  • JGP Wealth Management reported no remaining Bristol-Myers Squibb position as of Q3 2022 after selling out during the quarter.
  • JGP Wealth Management sold 2,690 Bristol-Myers Squibb shares in Q3 2022, an estimated $205K.
  • JGP Wealth Management first reported a position in Bristol-Myers Squibb in Q1 2022 and held it in 2 quarters.
  • JGP Wealth Management's Bristol-Myers Squibb position peaked at $208K in Q1 2022.
  • 2,470 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2022.

Based on JGP Wealth Management's 13F filing for Q3 2022, filed 14 Oct 2022.